Non-toxic flakes for authentication of pharmaceutical articles
View Patent ↗In one embodiment of the present invention, non-toxic inorganic flakes are used for identification and anticounterfeit protection of pharmaceutical articles, such as pills, tablets and capsules, having a core of a biologically active material and/or a biologically inert material. Non-toxic inorganic authentication flakes, either optically variable flakes or taggant flakes having one or more symbols and/or a selected shape are disposed on the surface or inside of the pharmaceutical article.
1. A pharmaceutical, nutraceutical, or veterinarian unit-dosage article having a surface, comprising: a material selected from the group consisting of a biologically active material and a biologically inert material, and a mixture thereof; and authentication flakes selected from the group consisting of non-toxic, inorganic optically variable flakes having at least one metallic layer and non-toxic, inorganic taggant flakes; wherein the authentication flakes are dispersed within the article or on the surface.
2. An article defined in claim 1 , wherein the material forms a core of the article; wherein the article further comprises a coating on at least a portion of the core, and wherein the authentication flakes are dispersed within the coating.
3. An article defined in claim 2 , wherein the core is selected from the group consisting of a liquid, a powder, and granules, and wherein the coating forms a capsule case around the core.
4. An article defined in claim 2 , wherein the authentication flakes form less than 10% by weight of the coating.
5. An article defined in claim 1 , wherein the authentication flakes are non-toxic, inorganic taggant flakes having a predetermined shape.
6. An article defined in claim 1 , wherein the authentication flakes are non-toxic, inorganic taggant flakes having indicia or a grating pattern thereon.
7. An article defined in claim 1 , wherein the authentication flakes are non-toxic, inorganic taggant flakes having one or more frame borders along an edge thereof.
8. An article defined in claim 1 , wherein the authentication flakes are non-toxic, single-layer dielectric taggant flakes.
9. An article defined in claim 1 , wherein the authentication flakes are clear or colored taggant flakes.
10. An article defined in claim 1 , wherein the authentication flakes are non-toxic, dielectric covert taggant flakes.
11. An article defined in claim 1 , wherein the authentication flakes are non-toxic taggant flakes comprising a material selected from the group consisting of zinc, magnesium, iron, titanium, gold, and silver.
12. An article defined in claim 1 , wherein the authentication flakes are optically variable non-toxic flakes, each comprising a non-toxic reflector layer, a non-toxic absorber layer, and a non-toxic dielectric layer therebetween.
13. An article defined in claim 12 , wherein the non-toxic absorber layer comprises a material selected from the group consisting of iron, zinc, magnesium, iron, titanium, gold, and silver.
14. An article defined in claim 12 , wherein the non-toxic reflector layer comprises a material selected from the group consisting of zinc, magnesium, iron, titanium, gold, and silver.
15. An article defined in claim 1 , wherein the authentication flakes include a material selected from the group consisting of: TiO 2 , TiO, SiO, SiO 2 , ZnO, MgO, and oxides of iron.
16. An article defined in claim 1 , wherein the authentication flakes are dispersed within the article and wherein the authentication flakes form less than 5% by weight of the article.
17. An article defined in claim 16 , wherein the authentication flakes are dispersed within the article and wherein the authentication flakes form less than 1% by weight of the article.
18. A pharmaceutical, nutraceutical, or veterinarian ointment comprising: an ointment base selected from the group consisting of a biologically active material and a biologically inert material, and a mixture thereof; and authentication flakes selected from the group consisting of non-toxic, inorganic optically variable flakes and non-toxic, inorganic taggant flakes; and wherein the authentication flakes are dispersed within the ointment base.
19. An article defined in claim 18 , wherein the authentication flakes form less than 5% of the ointment by weight.
20. An article defined in claim 18 , wherein the authentication flakes are one selected from the group of taggant flakes having a predetermined shape, taggant flakes having one or more frame borders along an edge thereof, taggant flakes having indicia or a grating pattern thereon, single-layered clear dielectric taggant flakes, and single-layered colored taggant flakes.